Document Detail


Skin barrier dysfunction and systemic sensitization to allergens through the skin.
MedLine Citation:
PMID:  16248822     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Most allergic, atopic and hypersensitive reactions are associated with Th2-biased immune responses and allergen-specific IgE antibodies. Pathological allergic disorders are on an alarming increase in the industrialized world. Understanding the mechanism of primary sensitization to allergens is important in elucidating the pathogenesis of these diseases and for possibly preventing their development. In this article, we review recent information supporting that epidermal allergen exposure may contribute to systemic allergic diseases and that atopy may be secondary to skin barrier dysfunction in some dermatoses. The skin is an active immunological organ, which functions as a primary defence and biosensor to the external environment. The critical permeability barrier function is mediated by the outmost layer of the epidermis, the stratum corneum. Perturbation of the stratum corneum initiates a chain of event, which activates homeostatic responses in the underlying epidermis. Repeated barrier-disruption, whether environmentally or genetically determined, may however stimulate signaling cascades that lead to inflammation and epidermal hyperplasia. Skin barrier dysfunction may also allow entry of allergens, which can lead to primary systemic sensitization. The altered epidermal microenvironment in barrier-disrupted skin appears to be particularly well suited for the induction of potent Th2-type responses with production of allergen-specific IgE. Epidermal exposure to food antigens can prevent the normal induction of oral tolerance and also lead to airway eosinophilia following inhalation. Exposure to allergens on barrier-disrupted skin may as such serve as a natural sensitization pathway for food allergy and respiratory allergic disease.
Authors:
Jessica Strid; Stephan Strobel
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current drug targets. Inflammation and allergy     Volume:  4     ISSN:  1568-010X     ISO Abbreviation:  Curr Drug Targets Inflamm Allergy     Publication Date:  2005 Oct 
Date Detail:
Created Date:  2005-10-26     Completed Date:  2005-11-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160019     Medline TA:  Curr Drug Targets Inflamm Allergy     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  531-41     Citation Subset:  IM    
Affiliation:
Immunobiology Unit, Institute of Child Health, University College London, London WC1N 1EH, UK. j.strid@ich.ucl.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Allergens / immunology*
Animals
Dermatitis, Atopic / etiology
Epidermis / metabolism
Genetic Predisposition to Disease
Humans
Hypersensitivity / etiology*,  prevention & control
Immune Tolerance
Langerhans Cells / metabolism
Life Style
Skin / immunology,  metabolism*
Chemical
Reg. No./Substance:
0/Allergens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Perinatal events affecting the onset of allergic diseases.
Next Document:  Pharmaceutical treatment of asthma in children.